HOME Research Insight Agreement, Collaborations and Partnerships Were the Most Widely Adopted Strategy in the Genome Editing Market



Agreement, Collaborations and Partnerships Were the Most Widely Adopted Strategy in the Genome Editing Market


Genome editing techniques are widely used in drug discovery by pharmaceutical and biotechnology companies. Research institutes are increasingly using genome editing products for studying cell line and animal & plant genetic engineering, which are the major applications of genome editing techniques. Genome editing and gene modification technologies have developed a broad range of solutions to create modified genes, expression systems, and stable cell lines. Current research in genetic engineering of animals is oriented towards a variety of possible medical, pharmaceutical, and agricultural applications. Furthermore, genome editing and gene modification technologies have developed a broad range of solutions to create modified genes, expression systems, and stable cell lines.

Major players in the genome editing market include GenScript USA Inc. (U.S.), Horizon Discovery Group plc (U.K.), Integrated DNA Technologies, Inc. (U.S.), Lonza Group Ltd. (Switzerland), New England Biolabs, Inc. (U.S.), OriGene Technologies, Inc. (U.S.), Sangamo Biosciences, Inc. (U.S.), Sigma-Aldrich Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), and Transposagen Biopharmaceuticals, Inc. (U.S.).

The global genome editing market is highly evolved, with multiple different product segments. An analysis of the market developments between 2012 and 2015 revealed that agreements, collaborations, and expansions were the most important growth strategies employed by market leaders in this period. This strategy was adopted by most players in this market except for Integrated DNA Technologies, Inc. (U.S.) and OriGene Technologies, Inc. (U.S.).

The other important growth strategy adopted by players in this market is new product launches. This strategy was adopted by players to gain immediate technological competency and to enhance their product portfolios. This strategy was adopted by all the players in this market except for GenScript USA Inc. (U.S.), Integrated DNA Technologies, Inc. (U.S.), and Sangamo Biosciences, Inc. (U.S.).

Related Reports:

Genome Editing / Genome Engineering Market, by Application (Cell Line Engineering, Animal & Plant Genetic Engineering), Technology (CRISPR, Antisense, TALEN, Zinc Finger Nuclease), & End User (Biotechnology & Pharmaceutical, CRO) Global Forecast to 2019.

Contact:
Mr. Rohan
North - Dominion Plaza,
17304 Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: sales@marketsandmarkets.com

Connect Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441

Search reports